产品说明书
Heparin
 |
同义名 : | - |
| CAS号 : | 9005-49-6 | |
| 货号 : | A802282 | |
| 分子式 : | - | |
| 纯度 : | 61.0IU/mg | |
| 分子量 : | 1134.93 | |
| MDL号 : | N/A | |
| 存储条件： |
粉末 Inert atmosphere,Store in freezer, under -20°C 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : | - | |
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Heparin (6 days) reduces the cytopathogenicity of HIV for MT-4 cells, with an IC50 of 7.5 μg/mL[2]. Heparin (0.5 U/mL, 48 h) inhibits HGF-induced trophoblast invasion in the SGHPL-4 cell line[3]. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01044888 | Off Pump Coronary Artery Bypas... 展开 >>s Surgery 收起 << | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Yonsei University Severance hospital Seoul, Seodaemungu, Korea, Republic of 收起 << |
| NCT02454491 | Heart Disease, Ischemic | Phase 4 | Completed | - | Italy ... 展开 >> University Hospital of Ferrara Cona, Ferrara, Italy, 44124 收起 << |
| NCT00912483 | Venous Thromboembolism | Phase 3 | Withdrawn | January 2011 | - |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
0.88mL 0.18mL 0.09mL |
4.41mL 0.88mL 0.44mL |
8.81mL 1.76mL 0.88mL |
| 参考文献 |
|---|